Alpha galactosylceramide liposomal (REGiMMUNE)

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NameAlpha galactosylceramide liposomal (REGiMMUNE)
Drug Alias NameToleroVaxRGI-2001liposomal RGI-7000RGI-7000 liposomalKRN-7000 liposomal +[7] 
ClassificationBiologics
Mechanisms of ActionCD1d antigens activatorsNKT cells stimulants
TargetsCD1d antigens
Therapy Area/IndicationsGraft vs Host DiseaseMyeloproliferative DisordersMyelodysplastic Syndromes +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanNetherlands
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesREGiMMUNE Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesREGiMMUNE Co LtdSan Fu Biotech Co Ltd
Inactive CompaniesThe Foundation For Liver Research
Active IndicationsGraft vs Host DiseaseMyeloproliferative DisordersMyelodysplastic Syndromes +[9] 
Inactive IndicationsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A